The research team of Prof. Wanliang Lu studied a recombinant targeted biological nanoparticle for in vitro expression of gene-editing proteins for epidermal growth factor receptor mutant lung cancer
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Wanliang Lu studied a recombinant targeted biological nanoparticle for in vitro expression of gene-editing proteins for epidermal growth factor receptor mutant lung cancer[J]. Journal of Chinese Pharmaceutical Sciences, 2026, 35(3): 327-327.
>
>